EUVIMEDEUVIMED entdecken
Crossref

Spatiotemporal-switchable 2D NIR-II single-atom nanozyme for single-cell–level surgical navigation and glioblastoma phototherapy

Ping Shangguan iD, Yong Zhong iD, Haigang Wu iD, Yisheng Liu iD, Gaoyang Wang iD, Cai Qi iD, Jiang Ouyang iD, Senfeng Zhao iD, Xin Wang iD, Jinlong Yin iD, Xiaoyuan Ji iD, Feng Bai iD und 4 weitere

Science Translational Medicine · 05.08.2026 · 18 (861)

DOI: 10.1126/scitranslmed.aeb8054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 05.08.2026. Verfasst von Ping Shangguan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Henan-Macquarie Uni Joint Centre for Biomedical Innovation, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, Henan International Joint Labora…. Hauptthemen laut MEDLINE: Glioblastoma, Phototherapy, Infrared Rays, Brain Neoplasms. Die Arbeit nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan, Henan Provincial Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single-cell–level resolution tumor therapy represents an advanced strategy against glioblastoma but lacks suitable theranostic agents. Here, we developed a spatiotemporal-switchable, two-dimensional (2D), bismuthene-based second near-infrared window (NIR-II) nanozyme. In this platform, the bismuthene scaffold simultaneously directed the assembly of indocyanine green (ICG) into ordered J -aggregates and anchored monodispersed platinum (Pt) atoms. The resulting J -aggregates acted as an optical antenna with a long-wavelength absorption peak at 895 nanometers and high photobleaching resistance of 78.0%, enabling the identification of single tumor cells with a resolution of 44.3 micrometers at 1350 nanometers for precise glioma resection. Postoperatively, the spatiotemporal-switchable function was activated for therapeutic intervention, in which the photothermal effect amplified the original efficiency of the catalase-like activity of Pt atoms by threefold, driving a surge in intracellular oxygen to combat tumor hypoxia. Upon 808-nanometer irradiation, the induced oxygen release in the tumor microenvironment amplified ICG-mediated photodynamic therapy, and combined with bismuthene-mediated photothermal therapy, it effectively inhibited residual tumors. In an orthotopic glioma mouse model, this approach minimized recurrence and achieved increased survival without inducing neurological or motor deficits. This work provides an atomic-level and molecular-level design blueprint for NIR-II nanotheranostic agents, paving the way toward clinical translation of single-cell–level precision medicine for brain malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaPhototherapyInfrared RaysBrain NeoplasmsNanoparticlesSingle-Cell AnalysisAnimalsHumansCell Line, TumorIndocyanine GreenMicePhotochemotherapyPlatinum

Substanzen

Indocyanine GreenPlatinum

Autor:innen und Institutionen

  • Henan-Macquarie Uni Joint Centre for Biomedical Innovation, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, Henan International Joint Laboratory of Nanobiomedicine, School of Life Sciences, Henan University, Ka…
  • Key Laboratory for Special Functional Materials of Ministry of Education, Henan University, Kaifeng, Henan 475004, China.
  • Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.
  • CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Nanozyme Medical Center, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.

ORCID-Profile: Ping Shangguan, Yong Zhong, Haigang Wu, Yisheng Liu, Gaoyang Wang, Cai Qi, Jiang Ouyang, Senfeng Zhao, Xin Wang, Jinlong Yin, Xiaoyuan Ji, Feng Bai, Kelong Fan, Jiefei Wang, Wei Tao, Bingyang Shi

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Henan
  • Henan Provincial Science and Technology Research Project
  • Key Research Projects of Higher Education Institutions in Henan Province
  • Postdoctral Fellowship Program of CPSF
  • China Postdoctoral Science Foundation
  • Science and Technology Innovation Talents in Universities of Henan Province

Zitieren

APA

Shangguan, P., Zhong, Y., Wu, H., Liu, Y., Wang, G., Qi, C., Ouyang, J., Zhao, S., Wang, X., Yin, J., Ji, X., Bai, F., Fan, K., Wang, J., Tao, W., & Shi, B. (2026). Spatiotemporal-switchable 2D NIR-II single-atom nanozyme for single-cell–level surgical navigation and glioblastoma phototherapy. Science Translational Medicine, 18(861). https://doi.org/10.1126/scitranslmed.aeb8054

Vancouver

Shangguan P, Zhong Y, Wu H, Liu Y, Wang G, Qi C, et al. Spatiotemporal-switchable 2D NIR-II single-atom nanozyme for single-cell–level surgical navigation and glioblastoma phototherapy. Science Translational Medicine. 2026;18(861). doi:10.1126/scitranslmed.aeb8054

BibTeX
@article{Shangguan2026,
  author = {Shangguan, Ping and Zhong, Yong and Wu, Haigang and Liu, Yisheng and Wang, Gaoyang and Qi, Cai and Ouyang, Jiang and Zhao, Senfeng and Wang, Xin and Yin, Jinlong and Ji, Xiaoyuan and Bai, Feng and Fan, Kelong and Wang, Jiefei and Tao, Wei and Shi, Bingyang},
  title = {Spatiotemporal-switchable 2D NIR-II single-atom nanozyme for single-cell–level surgical navigation and glioblastoma phototherapy},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {861},
  doi = {10.1126/scitranslmed.aeb8054}
}
Kostenlos starten →